Fingolimod Hydrochloridis CAS 162359-56-0 Puritas ≥99.0% (HPLC) API Factory High Purity Featured Image

Fingolimod Hydrochloridis CAS 162359-56-0 Puritas ≥99.0% (HPLC) API Factory High Munditia

Description:

Nomen chemicum: Fingolimod hydrochloride

CAS: 162359-56-0

Aspectus: Alba ad Off-White pulveris

Puritas: ≥99.0% (HPLC)

FDA probatum medicamentum pro curatione Sclerosis multiplex.

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer cum High puritate et stabulo Quality
Nomen chemicum: Fingolimod hydrochloride
CAS: 162359-56-0
Fingolimod hydrochloridum FDA probatum medicamentum pro curatio Sclerosis multiplex.
API High Quality, Commercial Production

Chemical Properties:

Nomen chemicum	Fingolimod hydrochloride
Synonyma	Fingolimod HCl;FTY 720
CAS Number	162359-56-0
CATTUS Number	RF-API39
Stock Status	In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae	C19H34ClNO2
M. Pondus	343.93
Liquescens punctum	102.0~ 107.0°C
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Off-White pulveris
Lepidium sativum	HPLC
Liquescens punctum	102.0~106.0℃
Solubilitas	Omnino solutum in aqua
Puritas / Analysis Methodus	≥99.0% (HPLC)
Humor (KF)	≤0.50%
Residere in Ignition	≤0.20%
Metalla gravis	≤20ppm
RELICTUM Solvents
Dichloromethane	≤0.05%
Ethyl Acetate	≤0.50%
Ethanol	≤0.50%
Methanol	≤0.30%
Toluene	≤0.089%
THF	≤0.50%
DMF	≤0.088%
Substantiae relativae
una immunditia	≤0.50%
Totalis immunditias	≤1.0%
Test Standard	Enterprise Standard
Consuetudinem	Active Pharmaceutical Ingredient (API)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et elit Fingolimod hydrochloridis (CAS: 162359-56-0) cum qualitate magna.
Fingolimod hydrochloridum primum medicamentum oris est pro curatione sclerosis multiplex.Feliciter a comitatu pharmaceutico Novartis explicatur et approbata est ad mercaturam Cibus US et Drug Administration (FDA).Multiplex sclerosis est morbus neurologicus debilitatus qui aegrotum facere potest sensum staterae amittere, apparent spasmos musculi et aliae perturbationes motus.Fingolimod hydrochloride receptor modulator sphingosinum-l-phosphatum (S1PR) est.Post phosphorylationem, oportet s1P receptorem in superficie lymphocytae, quae migrationem lymphocytam mutabit, et cellas in textum lymphaticum promoveat, et ne lymphocytes e lymphoideo relinquat et in surculum ingrediatur.Quocirca prohibebit has cellulas ne systema nervosum centrale (CNS), quod effectum immunosuppressionis attingit.